MabDesign is a French biotech startup, positioned as The Biotherapy Network. Founded in 2014, it aims to promote and support the growth of the local biotherapy industry. Headquartered in Lyon, at the heart of Europe, the company brings together the pharmaceutical sector to foster collaboration and innovation.
MabDesign's key mission is to structure, mobilize, and support the French industrial sector focused on biotherapy. It actively works to enhance companies' development and competitiveness, fostering the growth and production of biomolecules within France.
Despite limited details on recent investment activities, MabDesign presents an intriguing investment opportunity within the thriving biotech landscape of France. As the pharmaceutical industry continues to expand, MabDesign's strategic positioning and mission make it an entity worth considering for potential investors seeking exposure to the biotherapy sector.